MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The correlation studies between cholinergic cognitive impairment of Parkinson’s disease and the cortex thickness of brain

    Y. Zhang, B. Li (Guang Zhou, China)

    Objective: To determine whether cognitive domain impairment of visuospatial, memory, attention is related to dysfunction of brain cholinergic neurotransmitter system in mild cognitive impairment of…
  • 2018 International Congress

    Olfactory dysfunction predicting cognition

    X. Yu (Cleveland, OH, USA)

    Objective: To investigate the relationship between impairment in smell and cognitive function among older adults using both self-report and objective measurement of olfactory function. Background:…
  • 2018 International Congress

    Parkinsonism & Cognitive Dysfunction Severity Correlation in NPH with a Suggested Novel Phenotypic Subclassifcation of NPH

    A. Acharya, A. Biswas, S. Das (Kolkata, India)

    Objective: In this study, we have tried to find any correlation between severity of cognitive dysfunction and parkinsonism in NPH patients & to look for…
  • 2018 International Congress

    Relationship between Age-related Frailty and Intra-individual Variability of Reaction Time in Healthy Seniors: Implications for Parkinson’s disease

    L. Lu (Guangzhou, People’s Republic of China)

    Objective: To investigate the relationship between age-related frailty and intra-individual variability of reaction time in normal ageing people. Background: The neurobiological processes of normal aging…
  • 2018 International Congress

    Brief Cognitive Screening for Parkinson’s disease by the Korean Version of the Montreal Cognitive Assessment

    M. Park, D. Kwon (Ansan-city, Korea)

    Objective: We evaluated the screening ability of the Korean version of the Montreal Cognitive Assessment (K-MoCA) in the patients with Parkinson's disease. Background: The Montreal…
  • 2018 International Congress

    The relationship between family care giver number and progression speed of dementia

    Y. Liu, S.L. Yang, Y.C. Wu (Shanghai, China)

    Objective: Study the fact delays dementia progression. Background: Alzheimer’s disease is unrestored yet now. Relieving the life upset of patient and postponing the disease progression…
  • 2018 International Congress

    Angiotensin-converting enzyme inhibitors are neuroprotective regarding APOE-mediated motor and non-motor experiences for Alzheimer’s dementia but not for dementia with Lewy bodies

    F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti (São Paulo, Brazil)

    Objective: To assess whether angiotensin-converting enzyme (ACE) inhibitors modulate associations of biofluid concentrations and activity of ACE with motor and non-motor experiences in dementia with…
  • 2018 International Congress

    An open labeled, observational study for the Satisfaction and Preference of the Rivastigmine patch for treatment of Alzheimer’s disease and Parkinson’s disease dementia (SAFE-ADPD) in Koreans

    M. Park, D. Shin (Daegu, Republic of Korea)

    Objective: This study performed to access caregiver’s satisfaction and preference of the Rivastigmine patch for treatment of Alzheimer’s disease and Parkinson’s disease dementia patients to…
  • 2018 International Congress

    Cognition and emotion regulation in early onset ataxia

    M. Coenen, D. Sival, R. Brandsma, M. Tijssen, J. Spikman (Groningen, Netherlands)

    Objective: Evaluate cognition and emotion regulation of patients with early onset ataxia (EOA). Background: Early onset ataxia (EOA) is a movement disorder caused by a…
  • 2018 International Congress

    Efficacy and safety of Rasagiline in treatment of gait disturbances in dementia with Lewy bodies

    A. Chimagomedova, O. Levin, M. Anikina, I. Ayzenberg (Moscow, Russian Federation)

    Objective: We aimed to investigate the efficacy and safety of rasagiline in addition to levodopa in patients with dementia with Lewy bodies (DLB). Background: Management…
  • « Previous Page
  • 1
  • …
  • 1199
  • 1200
  • 1201
  • 1202
  • 1203
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley